We found that the number of TREM-2+monocytes in peripheral blood and the mean fluorescence intensity (MFI) of its expression significantly increased in the lung cancer patients and tumor-bearing mice compared to that in healthy controls (Figure 1A, 1B). This evidence concerns the gene TREM2 and lung carcinoma.